Maternal Autoimmune Disease Research Alliance (MADRA) Registry

Part of paid clinical trials in Durham, North Carolina.

Sponsor
Duke University
Study ID
NCT03276923
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
FEMALE
Age
N/A - N/A
Healthy Volunteers
Accepted

Study Details

This multi-site registry, centered at Duke University, will enroll pregnant women with autoimmune and rheumatologic diseases. The main goal of MADRA is to identify ways to improve the health of women with rheumatic diseases and their babies during pregnancy. Prior studies demonstrate the importance of increase inflammation prior to and during pregnancy on these outcomes. The future research will seek to better define these risk factors and to identify ways to may improve them.

Key Dates

Start date
Jan 1, 2018
Status verified
Jan 2026
Primary completion
Jan 1, 2027
Completion
Jan 1, 2027

Study Design

Enrollment
1,000 participants (estimated)

Arms

  • Arm: Maternal Autoimmune Disease ReseArch (MADRA) Registry
    Women with autoimmune diseases who are pregnant

Primary Outcome Measure

Risk factors associated with poor pregnancy outcomes as measured by the MADRA-DAP questionnaire. [ Time Frame: up to 10 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Duke UniversityDurhamNorth Carolina27705
Megan Clowse, MD
[email protected]
919 681 2045
Laura Neil
[email protected]
919 684 8936

Find similar trials in Durham, NC

By condition
Lupus (SLE)Rheumatoid arthritis
By specialty
RheumatologyAutoimmune diseaseMusculoskeletal disorders
By research site
Duke University· Durham, NC

Related Studies